AhmadBilalMalikMD

Associate Professor, Medicine, U of WA Sch of Med

Are you Dr. Malik?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Ahmad Malik, MD is a nephrologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Arkansas. He is affiliated with UW Medicine/University of Washington Medical Center and is an Associate Professor at U of WA Sch of Med.

University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Nephrology, 2005 - 2008
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Geriatric Medicine (Internal Medicine), 2001 - 2002
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1998 - 2001
King Edward Medical UniversityClass of 1996

PubMed

7 citations
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Shruti Gupta, Ian A Strohbehn, Qiyu Wang, Paul E Hanna, Rituvanthikaa Seethapathy
Kidney International. 2022-10-01
14 citations
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
Shruti Gupta, Clara Garcia-Carro, Jason M Prosek, Ilya Glezerman, Sandra M Herrmann
Journal for Immunotherapy of Cancer. 2022-09-01
108 citations
Acute kidney injury in patients treated with immune checkpoint inhibitors.
Shruti Gupta, Samuel A.P. Short, Meghan E. Sise, Jason Prosek, Sethu M. Madhavan
Journal for Immunotherapy of Cancer. 2021-10-01